Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
42.02
-0.72 (-1.68%)
At close: Sep 18, 2026, 4:00 PM EDT
41.00
-1.02 (-2.43%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Harmony Biosciences Holdings Employees
Harmony Biosciences Holdings had 293 employees as of December 31, 2025. The number of employees increased by 25 or 9.33% compared to the previous year.
Employees
293
Change (1Y)
25
Growth (1Y)
9.33%
Revenue / Employee
$3,276,102
Profits / Employee
$618,669
Market Cap
2.45B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | 25 | 9.33% |
| Dec 31, 2024 | 268 | 22 | 8.94% |
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Beam Therapeutics | 540 |
| Vera Therapeutics | 361 |
| Nurix Therapeutics | 317 |
| Structure Therapeutics | 281 |
| Viridian Therapeutics | 252 |
| Disc Medicine | 165 |
| Pharvaris | 148 |
| NewAmsterdam Pharma Company | 100 |
HRMY News
- 8 days ago - Harmony Biosciences Holdings Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 16 days ago - Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress - GlobeNewsWire
- 23 days ago - Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference - GlobeNewsWire
- 24 days ago - Harmony Biosciences initiated with an Outperform at Wolfe Research - TheFly
- 5 weeks ago - Harmony Biosciences Holdings Transcript: Piper Sandler Virtual CNS Symposium - Transcripts
- 6 weeks ago - Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium - GlobeNewsWire
- 6 weeks ago - Harmony Biosciences price target raised to $34 from $29 at Truist - TheFly
- 6 weeks ago - Harmony Biosciences price target raised to $39 from $36 at Deutsche Bank - TheFly